Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses. - Lin P; Shen G; Guo K; Qin S; Pu Q; Wang Z; Gao P; Xia Z; Khan N; Jiang J; Xia Q; Wu M (Nucleic acids research, 2022)